ICCM
Income statement / Annual
Last year (2023), IceCure Medical Ltd's total revenue was $3.23 M,
an increase of 4.67% from the previous year.
In 2023, IceCure Medical Ltd's net income was -$14.65 M.
See IceCure Medical Ltd’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$3.23 M
|
$3.09 M
|
$4.14 M
|
$4.08 M
|
$1.66 M
|
$1.07 M
|
$689,377.00
|
$625,487.00
|
$762,873.00
|
$1.07 M
|
| Cost of Revenue |
$1.93 M |
$1.64 M |
$1.94 M |
$1.43 M |
$1.08 M |
$623,174.00 |
$514,443.00 |
$403,993.00 |
$486,210.00 |
$692,102.00 |
| Gross Profit |
$1.30 M |
$1.45 M |
$2.20 M |
$2.66 M |
$576,413.00 |
$448,728.00 |
$174,934.00 |
$221,494.00 |
$276,663.00 |
$376,484.00 |
| Gross Profit Ratio |
0.4 |
0.47 |
0.53 |
0.65 |
0.35 |
0.42 |
0.25 |
0.35 |
0.36 |
0.35 |
| Research and Development
Expenses |
$8.27 M
|
$9.12 M
|
$5.88 M
|
$4.08 M
|
$2.85 M
|
$1.94 M
|
$1.50 M
|
$1.66 M
|
$980,874.00
|
$1.01 M
|
| General & Administrative
Expenses |
$4.17 M
|
$5.86 M
|
$4.13 M
|
$1.76 M
|
$1.32 M
|
$1.07 M
|
$1.02 M
|
$943,950.00
|
$1.34 M
|
$1.30 M
|
| Selling & Marketing
Expenses |
$4.44 M
|
$3.20 M
|
$1.92 M
|
$1.11 M
|
$1.02 M
|
$612,553.00
|
$319,657.00
|
$716,996.00
|
$1.49 M
|
$2.17 M
|
| Selling, General &
Administrative Expenses |
$8.60 M
|
$9.06 M
|
$6.04 M
|
$2.87 M
|
$2.34 M
|
$1.68 M
|
$1.34 M
|
$1.66 M
|
$2.82 M
|
$3.47 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$70,594.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$16.88 M |
$18.18 M |
$11.92 M |
$7.02 M |
$5.19 M |
$3.62 M |
$2.84 M |
$3.33 M |
$3.81 M |
$4.47 M |
| Cost And Expenses |
$18.81 M |
$19.82 M |
$13.86 M |
$8.45 M |
$6.27 M |
$4.24 M |
$3.35 M |
$3.73 M |
$4.29 M |
$5.16 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$4,042.85 |
-$178,757.98 |
$531.04 |
$2,014.04 |
$3,899.55 |
$8,709.77 |
$12,583.00 |
| Interest Expense |
$0.00 |
$239,000.00 |
$0.00 |
$31,720.00 |
$22,813.00 |
$63,459.00 |
$58,119.00 |
$154,942.00 |
$198,531.00 |
$639,969.00 |
| Depreciation &
Amortization |
$323,000.00
|
$248,000.00
|
$127,000.00
|
$63,000.00
|
$155,365.00
|
$30,800.00
|
$33,375.00
|
$54,073.00
|
$63,017.00
|
$112,996.00
|
| EBITDA |
-$15.25 M
|
-$16.49 M
|
-$9.60 M
|
-$4.08 M
|
-$4.60 M
|
-$3.42 M
|
-$2.75 M
|
-$3.03 M
|
-$3.69 M
|
-$3.98 M
|
| EBITDA Ratio |
-4.72 |
-5.35 |
-2.32 |
-1.06 |
-2.79 |
-3.19 |
-3.99 |
-4.85 |
-4.5 |
-3.74 |
| Operating Income Ratio
|
-4.82
|
-5.43
|
-2.35
|
-1.07
|
-2.78
|
-2.96
|
-3.87
|
-4.96
|
-4.63
|
-3.83
|
| Total Other
Income/Expenses Net |
$924,000.00
|
-$239,000.00
|
-$171,000.00
|
$412,000.00
|
-$165,184.24
|
-$363,761.88
|
-$210,898.84
|
-$166,640.67
|
-$222,867.77
|
-$618,398.38
|
| Income Before Tax |
-$14.65 M |
-$16.98 M |
-$9.90 M |
-$4.69 M |
-$4.77 M |
-$3.53 M |
-$2.88 M |
-$3.27 M |
-$3.75 M |
-$4.71 M |
| Income Before Tax Ratio
|
-4.54
|
-5.5
|
-2.39
|
-1.15
|
-2.88
|
-3.3
|
-4.17
|
-5.23
|
-4.92
|
-4.41
|
| Income Tax Expense |
$0.00 |
$239,000.00 |
$171,000.00 |
$86,765.00 |
-$13,572.83 |
-$1.13 M |
-$640,929.57 |
-$458,761.14 |
-$614,086.32 |
-$1.80 M |
| Net Income |
-$14.65 M |
-$17.22 M |
-$10.07 M |
-$4.78 M |
-$4.76 M |
-$3.53 M |
-$2.88 M |
-$3.27 M |
-$3.75 M |
-$4.71 M |
| Net Income Ratio |
-4.54 |
-5.58 |
-2.43 |
-1.17 |
-2.87 |
-3.3 |
-4.17 |
-5.23 |
-4.92 |
-4.41 |
| EPS |
-0.32 |
-0.47 |
-0.35 |
-0.28 |
-0.35 |
-0.3 |
-0.46 |
-0.62 |
-1.15 |
-3.69 |
| EPS Diluted |
-0.32 |
-0.47 |
-0.35 |
-0.28 |
-0.35 |
-0.3 |
-0.46 |
-0.62 |
-1.15 |
-3.69 |
| Weighted Average Shares
Out |
$45.64 M
|
$37.02 M
|
$28.55 M
|
$17.13 M
|
$13.62 M
|
$11.67 M
|
$6.26 M
|
$5.30 M
|
$3.27 M
|
$1.28 M
|
| Weighted Average Shares
Out Diluted |
$45.64 M
|
$37.02 M
|
$28.55 M
|
$17.13 M
|
$13.62 M
|
$11.67 M
|
$6.26 M
|
$5.30 M
|
$3.27 M
|
$1.28 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
